| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $200.9M | +40.8% |
| SG&A Expense | $62.5M | +37.5% |
| Operating Income | -$263.5M | -4.5% |
| Pre-tax Income | -$243.6M | -3.4% |
| Income Tax | $178K | -33.6% |
| Net Income | -$243.8M | -3.3% |
| EPS (Basic) | -$1.53 | +57.9% |
| EPS (Diluted) | -$1.53 | +57.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.1M | -62.0% |
| Short-term Investments | $165.4M | +106.9% |
| Current Assets | $314.1M | -34.3% |
| Total Assets | $317.0M | -36.1% |
| Current Liabilities | $29.9M | +19.0% |
| Total Liabilities | $29.9M | +10.3% |
| Stockholders' Equity | $287.1M | -38.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$182.9M | -12.0% |
| Capital Expenditures | $117K | +0.0% |
| Investing Cash Flow | -$70.6M | -209.6% |
| Financing Cash Flow | $21.6M | -90.7% |
| Free Cash Flow | -$183.1M | -12.0% |